Stay in the know. Check here regularly to see important activities and industry news.
In partnership with Children’s Hospital Colorado, STAQ has launched pre-filled, pediatric concentrations and doses of several important sterile compounded medications widely used in pediatric hospitals. Read the full article here.
Each year, the Colorado BioScience Association (CBSA) celebrates the companies and organizations driving new health innovations to save and change lives around the world. On December 10, 2020, STAQ was named a Finalist for company of the year, becoming one of just two companies among 720 to receive this honor.
STAQ’s co-founder and CEO, Joe Bagan, has some exciting things to say about the growth and future of 503Bs. Read the full story as profiled by Company this week.
For the past 13 years, Pharmacy Purchasing & Products magazine has devoted its April issue to the State of Compounding. “STAQ is honored to be nationally ranked as a top 503b facility for 2020,” said Mark Spiecker, President. “Having only recently opened our doors, we look forward to serving even more of you and becoming your trusted outsourced compounding resource.”
The Colorado Office of Economic Development and International Trade awarded STAQ an early stage retention grant in support of its innovative technologies and creation of viable products that help advance the state’s key industries. STAQ was acknowledged for being the first in its industry to develop and deploy robotic syringe filling in compounded medications.
For archived news items click here.